Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2022 Q3

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2022-11-03 For: 2022-09-30
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).

Headline figures

Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$22.41M
up 4.0% from $21.54M a year earlier
Net loss
$19.04M
compared with a net loss of $20.95M a year earlier
Diluted EPS
-$0.11
compared with -$0.12 a year earlier